Form 4: Calix CEO Michael Weening Exercises Stock Options and Sells Shares Under Pre-Arranged 10b5-1 Plan

Calix, Inc. President and CEO Michael Weening exercised stock options and subsequently sold 100,000 shares of common stock for approximately $4.66 million, as reported in a recent SEC Form 4 filing.

Summary

• Michael Weening, President & CEO and Director of Calix, Inc. (CALX), reported transactions on June 2, 2025.
• Mr. Weening acquired 80,000 shares of Common Stock by exercising stock options at a price of $6.38 per share.
• He also acquired an additional 20,000 shares of Common Stock by exercising stock options at a price of $5.95 per share.
• Immediately following these acquisitions, Mr. Weening disposed of 100,000 shares of Common Stock through a sale at a weighted average price of $46.5871 per share.
• The sales were executed in multiple transactions with prices ranging from $46.025 to $47.005 per share.
• The transactions were conducted pursuant to a previously established Rule 10b5-1 trading plan.
• Following these transactions, Mr. Weening directly beneficially owns 15,812 shares of Common Stock.
• He also retains beneficial ownership of 184,000 derivative securities (stock options).

Sentiment

Score: 7

Explanation: The sentiment is moderately positive. While insider selling can sometimes be viewed negatively, the significant profit realized by the CEO from option exercises, combined with the execution under a pre-planned 10b5-1 trading plan, mitigates potential negative interpretations. It reflects a standard practice for executives to monetize vested equity.

Positives

• The exercise of stock options at significantly lower prices ($6.38 and $5.95) compared to the sale price ($46.5871) indicates a substantial profit for the insider.
• The execution of sales under a Rule 10b5-1 trading plan suggests a pre-planned, non-discretionary transaction, which can mitigate concerns about insider selling based on new material non-public information.

Negatives

• The sale of 100,000 shares by a key executive like the President & CEO could be perceived negatively by some investors, potentially signaling a lack of confidence, even if executed under a 10b5-1 plan.

Future Outlook

This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Management Comments

• "Sales reported on the Form 4 were effected pursuant to a previously established Rule 10b5-1 trading plan."

Industry Context

This SEC Form 4 filing details an insider transaction by a key executive at Calix, Inc. While specific to the company, such transactions are common across all industries for executives managing their equity compensation and personal financial planning. The use of a 10b5-1 plan is a standard practice for insiders to sell shares in a compliant manner.

Stakeholder Impact

• Shareholders: May observe the CEO's sale of shares, but the 10b5-1 plan context should alleviate concerns about discretionary selling based on adverse non-public information. The transaction demonstrates the value of executive equity compensation.

Key Dates

Keywords

Calix, CALX, Form 4, Insider Trading, Stock Options, Share Sale, Michael Weening, 10b5-1 Plan, Executive Compensation, Beneficial Ownership